查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532276

妊娠紋治療市場：2024-2033年全球產業分析、規模、佔有率、成長、趨勢、預測

Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球妊娠紋治療市場的綜合報告。本報告全面評估了主要市場動態，包括市場驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • 妊娠紋治療市場規模（2024年）：29億美元
  • 預測市值（2033年）：46億美元
  • 全球市場成長率（2024年至2033年年複合成長率）：5.3%

妊娠紋治療市場 - 報告範圍：

妊娠紋是一種常見的皮膚病，是由於皮膚快速拉伸引起的，又稱為皮紋或皮紋。妊娠紋治療市場包括各種治療選擇，例如局部治療、雷射治療和手術介入。這些治療目的是減少妊娠紋的出現並改善皮膚紋理。該市場服務於廣泛的客戶，包括尋求美容改善的個人、提供專業治療的醫療保健提供者以及提供先進解決方案的美容診所。市場成長的驅動力是人們對皮膚美容意識的提高、生活方式和荷爾蒙變化導致的妊娠紋患病率上升以及治療技術的進步。

市場驅動因素：

全球妊娠紋治療市場由幾個關鍵因素推動，例如人們對有效治療方案可用性的認識不斷提高。由於懷孕、體重快速增加和青春期等因素，妊娠紋的發生率不斷增加，導致治療需求增加。技術進步，例如非侵入性雷射治療和增強的局部製劑的開發，提高療效和患者舒適度。此外，美學的提高和對整容手術的日益重視推動市場擴張。可支配收入的增加和個人化護膚趨勢的成長進一步促進了市場的成長。

市場限制因素：

儘管成長前景廣闊，妊娠紋治療市場仍面臨成本和可及性方面的挑戰。雷射治療和外科手術等先進治療方法價格昂貴，某些人可能無法接受。此外，治療效果可能會因個人皮膚類型和妊娠紋嚴重程度而異，這可能會影響患者滿意度和治療結果。市場也面臨監管合規性以及需要持續研究以驗證治療有效性和安全性的挑戰。

市場機會：

由於技術創新、人口趨勢和不斷變化的消費者偏好，妊娠紋治療市場提供了巨大的成長機會。射頻和超音波治療等新技術的整合增強治療選擇。對個人化皮膚護理解決方案的日益關注和微創手術的日益普及為市場參與者開闢了新的途徑。策略合作夥伴關係、研發投資以及引進負擔得起且有效的治療方法對於利用新機會和維持市場領先地位非常重要。

本報告涵蓋的主要問題

  • 推動全球妊娠紋治療市場成長的關鍵因素是什麼？
  • 哪些類型的治療和應用推動不同患者群體的採用？
  • 技術進步如何改變妊娠紋治療市場的競爭格局？
  • 誰是妊娠紋治療市場的主要參與者？
  • 全球妊娠紋治療市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 治療類型創新/發展趨勢

第4章 關鍵成功因素

  • 波特的分析
  • PESTEL 分析
  • 皮膚科/美容外科醫生，主要國家
  • 主要國家的皮膚科/美容外科診所
  • 依地區劃分的美容護理數量
  • 依地區劃分的懷孕人數
  • 付款人組合分析
  • 主要參與者的促銷策略
  • 醫療保健償付和資金結構
  • 監管場景
  • 母市場分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 動態

第6章 COVID-19 危機 - 影響評估

  • 新冠肺炎（COVID-19）與影響分析
    • 依治療類型
    • 依妊娠紋類型
    • 依最終用戶
    • 依地區
  • 2023年市場情景

第7章 全球市場需求（金額或規模）分析

  • 2019-2023年市場價值分析
  • 2024-2033年市場價值預測
    • 年成長趨勢分析
    • 絕對的獲利機會

第8章 依治療類型：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模（金額與數量）分析
  • 2024-2033年市場規模（金額和數量）分析與預測
    • 外用藥
      • 凝膠
      • 乳膏
      • 油/精華液
    • 手術治療
      • 高頻療法
      • 非 非汽化剝離式雷射點陣換膚
      • 燒蝕雷射換膚
      • 紅外線裝置/輻射
      • 皮膚剝離
      • 化學剝離
  • 依治療類型的市場吸引力分析

第9章 妊娠紋類型：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模（金額）分析
  • 2024-2033年市場規模（金額）分析與預測
    • 萎縮性皮紋（皮膚薄化）
    • 妊娠紋（懷孕後）
    • 妊娠擴張紋
    • 紅色條紋
    • 白色條紋
    • 黑色條紋
    • 藍色條紋
  • 依妊娠紋類型：市場吸引力分析

第10章 依最終使用者：世界市場分析

  • 簡介/主要發現
  • 2019-2023年市場規模（金額）分析
  • 2024-2033年市場規模（金額）分析與預測
    • 醫院
    • 皮膚科診所
    • 美容診所
    • 健康與水療中心
    • 居家照護環境
  • 依最終用戶的市場吸引力分析

第11章 依區域：世界市場分析

  • 簡介
  • 2019-2023年市場規模（金額）分析
  • 2024-2033年市場規模（金額）分析與預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東和非洲（中東、非洲）
  • 依區域市場吸引力分析

第12章 北美市場分析

第13章 拉丁美洲市場分析

第14章 歐洲市場分析

第15章 南亞市場分析

第16章 東亞市場分析

第17章 大洋洲市場分析

第18章 中東、非洲市場分析

第19章 市場結構分析

  • 依公司層級的市場分析
  • 主要公司市佔率分析
  • 市場現況分析

第20章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳情
    • Weleda
    • Clarins
    • basq NYC
    • Body Merry
    • Himalaya Global Holdings Ltd.
    • Stratpharma AG（Stratpharma Inc.）
    • Browne Drug Co., Inc.（Palmer's）
    • Mederma（HRA Pharma）
    • Givaudan SA
    • NEOSTRATA COMPANY, INC.（Johnson &Johnson Services, Inc.）
    • Bio-Oil（Union Swiss（Pty）Ltd）
    • Merz Pharma
    • Dermaclara
    • Unilever

第21章 使用的先決條件與縮寫

第22章 研究方法

簡介目錄
Product Code: PMRREP33375

Persistence Market Research has recently released a comprehensive report on the global stretch marks treatment market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Stretch Marks Treatment Market Size (2024E): USD 2.9 Billion
  • Projected Market Value (2033F): USD 4.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Stretch Marks Treatment Market - Report Scope:

Stretch marks, also known as striae or striae distensae, are a common skin condition that occurs due to rapid stretching of the skin. The stretch marks treatment market encompasses various therapeutic options, including topical treatments, laser therapies, and surgical interventions. These treatments aim to reduce the appearance of stretch marks and improve skin texture. The market serves a wide range of customers, including individuals seeking cosmetic improvements, healthcare providers offering specialized treatments, and aesthetic clinics providing advanced solutions. Market growth is driven by increasing awareness of skin aesthetics, rising prevalence of stretch marks due to lifestyle and hormonal changes, and advancements in treatment technologies.

Market Growth Drivers:

The global stretch marks treatment market is propelled by several key factors, including growing awareness about the availability of effective treatment options. Increasing instances of stretch marks due to factors such as pregnancy, rapid weight gain, and puberty contribute to the rising demand for treatments. Technological advancements, such as the development of non-invasive laser treatments and enhanced topical formulations, offer improved efficacy and patient comfort. Additionally, the increasing emphasis on aesthetic enhancements and cosmetic procedures is driving market expansion. The rise in disposable incomes and the growing trend of personalized skincare further contribute to market growth.

Market Restraints:

Despite promising growth prospects, the stretch marks treatment market faces challenges related to cost and accessibility. The high cost of advanced treatments, such as laser therapies and surgical interventions, can limit accessibility for some individuals. Additionally, the effectiveness of treatments can vary depending on individual skin types and the severity of the stretch marks, which may affect patient satisfaction and treatment outcomes. The market also encounters challenges related to regulatory compliance and the need for continued research to validate treatment efficacy and safety.

Market Opportunities:

The stretch marks treatment market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving consumer preferences. The integration of new technologies, such as radiofrequency and ultrasound-based treatments, offers enhanced treatment options. The increasing focus on personalized skincare solutions and the growing popularity of minimally invasive procedures create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of affordable and effective treatments are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stretch marks treatment market globally?
  • Which treatment types and applications are driving adoption across different patient demographics?
  • How are technological advancements reshaping the competitive landscape of the stretch marks treatment market?
  • Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

Leading players in the global stretch marks treatment market, including Allergan PLC, Revance Therapeutics, Inc., and Syneron Candela, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including novel topical agents, laser devices, and minimally invasive procedures. Collaborations with dermatologists, aesthetic clinics, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the dynamic stretch marks treatment landscape.

Key Companies Profiled:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer's)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Key Segments of Stretch Marks Treatment Industry Research

By Treatment:

  • Topical Medications
  • Procedural Treatments

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Treatment Type Innovation / Development Trends

4. Key Success Factors

  • 4.1. Porter's Analysis
  • 4.2. PESTEL Analysis
  • 4.3. Dermatologists/Cosmetic Surgeons, Key Country
  • 4.4. Dermatology/Cosmetic Surgery Clinics, Key Country
  • 4.5. Number of Aesthetic Procedures, By Region
  • 4.6. Number of Pregnancy, By Region
  • 4.7. Payer Mix Analysis
  • 4.8. Promotional Strategies, By Key Players
  • 4.9. Healthcare Reimbursement and Financing Structure
  • 4.10. Regulatory Scenario
  • 4.11. Parent Market Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Life Expectancy Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Cases of Pregnancy
    • 5.2.2. Rising Disposable Per Capita Income
    • 5.2.3. Adoption of Aesthetic Treatments
    • 5.2.4. Changes in Lifestyle
    • 5.2.5. Shift from Invasive to Non-invasive Laser Therapies
    • 5.2.6. Presence of Highly Skilled Workforce
    • 5.2.7. Media Coverage and Awareness from Celebrities
    • 5.2.8. New/Improved Product Launches
    • 5.2.9. Growing Investment in Healthcare Expenditure
    • 5.2.10. Mergers and Acquisitions
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Treatment Type
    • 6.1.2. By Stretch Marks Type
    • 6.1.3. BY End User
    • 6.1.4. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
    • 8.3.1. Topical Medications
      • 8.3.1.1. Gels
      • 8.3.1.2. Creams
      • 8.3.1.3. Oils/Serums
    • 8.3.2. Procedural Treatments
      • 8.3.2.1. Radiofrequency Therapy
      • 8.3.2.2. Nonablative Laser Fractional Resurfacing
      • 8.3.2.3. Ablative Laser Resurfacing
      • 8.3.2.4. Infrared Devices/Radiations
      • 8.3.2.5. Dermabrasion
      • 8.3.2.6. Chemical Peel
  • 8.4. Market Attractiveness Analysis By Treatment Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Stretch Marks Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Stretch Marks Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Stretch Marks Type, 2024-2033
    • 9.3.1. Striae Atrophicans (Thinned Skin)
    • 9.3.2. Striae Gravidarum (Post Pregnancy)
    • 9.3.3. Striae Distensae (Stretched Skin)
    • 9.3.4. Striae Rubrae (Red)
    • 9.3.5. Striae Albae (White)
    • 9.3.6. Striae Nigra (Black)
    • 9.3.7. Striae Caerulea (Dark Blue)
  • 9.4. Market Attractiveness Analysis By Stretch Marks Type

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Dermatology Clinics
    • 10.3.3. Aesthetic Clinics
    • 10.3.4. Wellness and Spa Centers
    • 10.3.5. Home Care Settings
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Treatment Type
    • 12.3.3. By Stretch Marks Type
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Treatment Type
    • 12.4.3. By Stretch Marks Type
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Market Analysis
      • 12.5.1.1. .Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Treatment Type
        • 12.5.1.2.2. By Stretch Marks Type
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Treatment Type
        • 12.5.2.2.2. By Stretch Marks Type
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Stretch Marks Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Treatment Type
    • 13.4.3. By Stretch Marks Type
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Market Analysis
      • 13.5.1.1. .Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Treatment Type
        • 13.5.1.2.2. By Stretch Marks Type
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Treatment Type
        • 13.5.2.2.2. By Stretch Marks Type
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Treatment Type
        • 13.5.3.2.2. By Stretch Marks Type
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Nordic Countries
      • 14.3.1.9. Rest of Europe
    • 14.3.2. By Treatment Type
    • 14.3.3. By Stretch Marks Type
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Treatment Type
    • 14.4.3. By Stretch Marks Type
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Market Analysis
      • 14.5.1.1. .Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Treatment Type
        • 14.5.1.2.2. By Stretch Marks Type
        • 14.5.1.2.3. By End User
    • 14.5.2. France Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Treatment Type
        • 14.5.2.2.2. By Stretch Marks Type
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Treatment Type
        • 14.5.3.2.2. By Stretch Marks Type
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Market Analysis
      • 14.5.4.1. .Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Treatment Type
        • 14.5.4.2.2. By Stretch Marks Type
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Market Analysis
      • 14.5.5.1. .Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Treatment Type
        • 14.5.5.2.2. By Stretch Marks Type
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Market Analysis
      • 14.5.6.1. .Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Treatment Type
        • 14.5.6.2.2. By Stretch Marks Type
        • 14.5.6.2.3. By End User
    • 14.5.7. Nordic Countries Market Analysis
      • 14.5.7.1. .Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Treatment Type
        • 14.5.7.2.2. By Stretch Marks Type
        • 14.5.7.2.3. By End User
    • 14.5.8. BENELUX Market Analysis
      • 14.5.8.1. .Introduction
      • 14.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.8.2.1. By Treatment Type
        • 14.5.8.2.2. By Stretch Marks Type
        • 14.5.8.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Treatment Type
    • 15.3.3. By Stretch Marks Type
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Treatment Type
    • 15.4.3. By Stretch Marks Type
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Market Analysis
      • 15.5.1.1. .Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Treatment Type
        • 15.5.1.2.2. By Stretch Marks Type
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Market Analysis
      • 15.5.2.1. .Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Treatment Type
        • 15.5.2.2.2. By Stretch Marks Type
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Treatment Type
        • 15.5.3.2.2. By Stretch Marks Type
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Treatment Type
        • 15.5.4.2.2. By Stretch Marks Type
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Treatment Type
    • 16.3.3. By Stretch Marks Type
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Treatment Type
    • 16.4.3. By Stretch Marks Type
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Market Analysis
      • 16.5.1.1. .Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Treatment Type
        • 16.5.1.2.2. By Stretch Marks Type
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Treatment Type
        • 16.5.2.2.2. By Stretch Marks Type
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Treatment Type
        • 16.5.3.2.2. By Stretch Marks Type
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Treatment Type
    • 17.3.3. By Stretch Marks Type
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Treatment Type
    • 17.4.3. By Stretch Marks Type
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Market Analysis
      • 17.5.1.1. .Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Treatment Type
        • 17.5.1.2.2. By Stretch Marks Type
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Treatment Type
        • 17.5.2.2.2. By Stretch Marks Type
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. Northern Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Treatment Type
    • 18.3.3. By Stretch Marks Type
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Treatment Type
    • 18.4.3. By Stretch Marks Type
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Market Analysis
      • 18.5.1.1. .Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Treatment Type
        • 18.5.1.2.2. By Stretch Marks Type
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkiye Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Treatment Type
        • 18.5.2.2.2. By Stretch Marks Type
        • 18.5.2.2.3. By End User
    • 18.5.3. Northern Africa Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Treatment Type
        • 18.5.3.2.2. By Stretch Marks Type
        • 18.5.3.2.3. By End User
    • 18.5.4. South Africa Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Treatment Type
        • 18.5.4.2.2. By Stretch Marks Type
        • 18.5.4.2.3. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Weleda
      • 20.3.1.1. Overview
      • 20.3.1.2. Treatment Type Portfolio
      • 20.3.1.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.1.4. Sales Footprint
      • 20.3.1.5. Strategy Overview
    • 20.3.2. Clarins
      • 20.3.2.1. Overview
      • 20.3.2.2. Treatment Type Portfolio
      • 20.3.2.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.2.4. Sales Footprint
      • 20.3.2.5. Strategy Overview
    • 20.3.3. basq NYC
      • 20.3.3.1. Overview
      • 20.3.3.2. Treatment Type Portfolio
      • 20.3.3.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.3.4. Sales Footprint
      • 20.3.3.5. Strategy Overview
    • 20.3.4. Body Merry
      • 20.3.4.1. Overview
      • 20.3.4.2. Treatment Type Portfolio
      • 20.3.4.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.4.4. Sales Footprint
      • 20.3.4.5. Strategy Overview
    • 20.3.5. Himalaya Global Holdings Ltd.
      • 20.3.5.1. Overview
      • 20.3.5.2. Treatment Type Portfolio
      • 20.3.5.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.5.4. Sales Footprint
      • 20.3.5.5. Strategy Overview
    • 20.3.6. Stratpharma AG (Stratpharma Inc.)
      • 20.3.6.1. Overview
      • 20.3.6.2. Treatment Type Portfolio
      • 20.3.6.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.6.4. Sales Footprint
      • 20.3.6.5. Strategy Overview
    • 20.3.7. Browne Drug Co., Inc. (Palmer's)
      • 20.3.7.1. Overview
      • 20.3.7.2. Treatment Type Portfolio
      • 20.3.7.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.7.4. Sales Footprint
      • 20.3.7.5. Strategy Overview
    • 20.3.8. Mederma (HRA Pharma)
      • 20.3.8.1. Overview
      • 20.3.8.2. Treatment Type Portfolio
      • 20.3.8.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.8.4. Sales Footprint
      • 20.3.8.5. Strategy Overview
    • 20.3.9. Givaudan SA
      • 20.3.9.1. Overview
      • 20.3.9.2. Treatment Type Portfolio
      • 20.3.9.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.9.4. Sales Footprint
      • 20.3.9.5. Strategy Overview
    • 20.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
      • 20.3.10.1. Overview
      • 20.3.10.2. Treatment Type Portfolio
      • 20.3.10.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.10.4. Sales Footprint
      • 20.3.10.5. Strategy Overview
    • 20.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
      • 20.3.11.1. Overview
      • 20.3.11.2. Treatment Type Portfolio
      • 20.3.11.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.11.4. Sales Footprint
      • 20.3.11.5. Strategy Overview
    • 20.3.12. Merz Pharma
      • 20.3.12.1. Overview
      • 20.3.12.2. Treatment Type Portfolio
      • 20.3.12.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.12.4. Sales Footprint
      • 20.3.12.5. Strategy Overview
    • 20.3.13. Dermaclara
      • 20.3.13.1. Overview
      • 20.3.13.2. Treatment Type Portfolio
      • 20.3.13.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.13.4. Sales Footprint
      • 20.3.13.5. Strategy Overview
    • 20.3.14. Unilever
      • 20.3.14.1. Overview
      • 20.3.14.2. Treatment Type Portfolio
      • 20.3.14.3. Profitability by Market Segments (Treatment Type/Region)
      • 20.3.14.4. Sales Footprint
      • 20.3.14.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology